Serologic Response to SARS-CoV-2 in COVID-19 Patients with Different Severity
Detection Principle
ImmunoAssay-Antibody
Target
IgM, IgG; ORF1ab, N
Testing Method Category
Mixed
Testing Method
kits
Testing Method - Additional Info
two commercial qPCR kits: (Daan Gene, Guangzhou, China and BGI, Shenzhen, China); semi-quantitative magnetic particle chemiluminescence immunoassays (M-CLIAs)
Reported Performance
consistency rate: 48.86% (qPCR and Ab test)
Sample Size
88 patients
Peer-reviewed
yes
The database contains available information from scientific literature that is being updated periodically. Please note that the provided information (as retrieved from analysed papers) is provided only for devices commercially available with CE-IVD mark. Acknowledgements